Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
25.46
+1.79 (7.56%)
Feb 18, 2026, 4:00 PM EST - Market closed
Pulse Biosciences Market Cap
Pulse Biosciences has a market cap or net worth of $1.73 billion as of February 18, 2026. Its market cap has increased by 34.01% in one year.
Market Cap
1.73B
Enterprise Value
1.64B
1-Year Change
34.01%
Ranking
Category
Stock Price
$25.46
Market Cap Chart
Since May 18, 2016, Pulse Biosciences's market cap has increased from $52.40M to $1.73B, an increase of 3,192.68%. That is a compound annual growth rate of 43.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 1.60B | 72.41% |
| Dec 31, 2025 | 930.40M | -13.13% |
| Dec 31, 2024 | 1.07B | 59.11% |
| Dec 29, 2023 | 673.10M | 552.86% |
| Dec 30, 2022 | 103.10M | -76.50% |
| Dec 31, 2021 | 438.80M | -27.42% |
| Dec 31, 2020 | 604.60M | 116.86% |
| Dec 31, 2019 | 278.80M | 43.19% |
| Dec 31, 2018 | 194.70M | -49.52% |
| Dec 29, 2017 | 385.70M | 345.90% |
| Dec 30, 2016 | 86.50M | 65.08% |
| May 18, 2016 | 52.40M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ICU Medical | 3.58B |
| Warby Parker | 2.74B |
| DENTSPLY SIRONA | 2.58B |
| LeMaitre Vascular | 1.99B |
| AtriCure | 1.62B |
| Kestra Medical Technologies | 1.57B |
| Azenta | 1.32B |
| BioLife Solutions | 1.07B |